186 related articles for article (PubMed ID: 33273485)
1. Assessment of a dried blood spot C-reactive protein method to identify disease flares in rheumatoid arthritis patients.
D'Cruz LG; McEleney KG; Cochrane C; Tan KBC; Shukla P; Gardiner PV; Small D; Zhang SD; Gibson DS
Sci Rep; 2020 Dec; 10(1):21089. PubMed ID: 33273485
[TBL] [Abstract][Full Text] [Related]
2. Validation of Biomarkers of CVD Risk from Dried Blood Spots in Community-Based Research: Methodologies and Study-Specific Serum Equivalencies.
Samuelsson LB; Hall MH; McLean S; Porter JH; Berkman L; Marino M; Sembajwe G; McDade TW; Buxton OM
Biodemography Soc Biol; 2015; 61(3):285-97. PubMed ID: 26652683
[TBL] [Abstract][Full Text] [Related]
3. Pain and Self-reported Swollen Joints Are Main Drivers of Patient-reported Flares in Rheumatoid Arthritis: Results from a 12-month Observational Study.
Kuettel D; Primdahl J; Weber U; Terslev L; Østergaard M; Petersen R; Pedersen AK; Möller S; Hørslev-Petersen K
J Rheumatol; 2020 Sep; 47(9):1305-1313. PubMed ID: 31787604
[TBL] [Abstract][Full Text] [Related]
4. Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Antipsychotics: Drawbacks of Its Clinical Application.
Kloosterboer SM; de Winter BCM; Bahmany S; Al-Hassany L; Dekker A; Dieleman GC; van Gelder T; Dierckx B; Koch BCP
Ther Drug Monit; 2018 Jun; 40(3):344-350. PubMed ID: 29505492
[TBL] [Abstract][Full Text] [Related]
5. Golimumab Dried Blood Spot Analysis (GOUDA): a Prospective Trial Showing Excellent Correlation with Venepuncture Samples and More Detailed Pharmacokinetic Information.
Detrez I; Schops G; Lefrère J; Tops S; Van Assche G; Vermeire S; Van Moerkercke W; Ferrante M; Gils A
AAPS J; 2018 Dec; 21(1):10. PubMed ID: 30564993
[TBL] [Abstract][Full Text] [Related]
6. Dried blood spot sampling of nilotinib in patients with chronic myeloid leukaemia: a comparison with venous blood sampling.
Boons CCLM; Chahbouni A; Schimmel AM; Wilhelm AJ; den Hartog YM; Janssen JJWM; Hendrikse NH; Hugtenburg JG; Swart EL
J Pharm Pharmacol; 2017 Oct; 69(10):1265-1274. PubMed ID: 28643375
[TBL] [Abstract][Full Text] [Related]
7. Flares in rheumatoid arthritis: do patient-reported swollen and tender joints match clinical and ultrasonography findings?
Kuettel D; Terslev L; Weber U; Østergaard M; Primdahl J; Petersen R; Ammitzbøll-Danielsen M; Möller S; Hørslev-Petersen K
Rheumatology (Oxford); 2020 Jan; 59(1):129-136. PubMed ID: 31382292
[TBL] [Abstract][Full Text] [Related]
8. Comparison of C-Reactive Protein in Dried Blood Spots and Saliva of Healthy Adolescents.
Plank AC; Maschke J; Rohleder N; Fasching PA; Beckmann MW; Kornhuber J; Eichler A; Moll GH; Kratz O
Front Immunol; 2021; 12():795580. PubMed ID: 34975902
[TBL] [Abstract][Full Text] [Related]
9. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis.
Chandrashekara S; Mukhtar Ahmad M; Renuka P; Anupama KR; Renuka K
Int J Rheum Dis; 2017 Oct; 20(10):1457-1467. PubMed ID: 28952205
[TBL] [Abstract][Full Text] [Related]
10. Serum matrix metalloproteinase 3 levels in comparison to C-reactive protein in periods with and without progression of radiological damage in patients with early rheumatoid arthritis.
Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
Clin Exp Rheumatol; 2003; 21(4):465-72. PubMed ID: 12942698
[TBL] [Abstract][Full Text] [Related]
11. Serum, plasma, and dried blood spot high-sensitivity C-reactive protein enzyme immunoassay for population research.
Brindle E; Fujita M; Shofer J; O'Connor KA
J Immunol Methods; 2010 Oct; 362(1-2):112-20. PubMed ID: 20850446
[TBL] [Abstract][Full Text] [Related]
12. Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole.
Martial LC; van den Hombergh E; Tump C; Halmingh O; Burger DM; van Maarseveen EM; Brüggemann RJ; Aarnoutse RE
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():16-23. PubMed ID: 29747155
[TBL] [Abstract][Full Text] [Related]
13. Optimization of flare management in patients with rheumatoid arthritis: results of a randomized controlled trial.
Myasoedova E; Crowson CS; Giblon RE; McCarthy-Fruin K; Schaffer DE; Wright K; Matteson EL; Davis JM
Clin Rheumatol; 2019 Nov; 38(11):3025-3032. PubMed ID: 31264032
[TBL] [Abstract][Full Text] [Related]
14. Agreement between the DAS28-CRP assessed with 3 and 4 variables in patients with rheumatoid arthritis treated with biological agents in the daily clinic.
Madsen OR
J Rheumatol; 2013 Apr; 40(4):379-85. PubMed ID: 23457377
[TBL] [Abstract][Full Text] [Related]
15. A Sweat-based Wearable Enabling Technology for Real-time Monitoring of IL-1β and CRP as Potential Markers for Inflammatory Bowel Disease.
Jagannath B; Lin KC; Pali M; Sankhala D; Muthukumar S; Prasad S
Inflamm Bowel Dis; 2020 Sep; 26(10):1533-1542. PubMed ID: 32720974
[TBL] [Abstract][Full Text] [Related]
16. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis.
Cunnane G; Fitzgerald O; Beeton C; Cawston TE; Bresnihan B
Arthritis Rheum; 2001 Oct; 44(10):2263-74. PubMed ID: 11665967
[TBL] [Abstract][Full Text] [Related]
17. Clinical validation of dried blood spot sampling in therapeutic drug monitoring of ciclosporin A in allogeneic stem cell transplant recipients: direct comparison between capillary and venous sampling.
Wilhelm AJ; Klijn A; den Burger JC; Visser OJ; Veldkamp AI; Janssen JJ; Swart EL
Ther Drug Monit; 2013 Feb; 35(1):92-5. PubMed ID: 23296096
[TBL] [Abstract][Full Text] [Related]
18. Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activity.
Holten K; Paulshus Sundlisæter N; Sexton J; Nordberg LB; Uhlig T; Kvien TK; Solomon DH; Haavardsholm EA; Lillegraven S; Aga AB;
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38216290
[TBL] [Abstract][Full Text] [Related]
19. Classifying Self-Reported Rheumatoid Arthritis Flares Using Daily Patient-Generated Data From a Smartphone App: Exploratory Analysis Applying Machine Learning Approaches.
Gandrup J; Selby DA; Dixon WG
JMIR Form Res; 2024 May; 8():e50679. PubMed ID: 38743480
[TBL] [Abstract][Full Text] [Related]
20. Dried blood spot analysis for therapeutic drug monitoring of pazopanib.
de Wit D; den Hartigh J; Gelderblom H; Qian Y; den Hollander M; Verheul H; Guchelaar HJ; van Erp NP
J Clin Pharmacol; 2015 Dec; 55(12):1344-50. PubMed ID: 26032288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
